Of note, two PLA2 transcripts, PLA2G16 (AdPLA2) and PLA2G4C, were significantly higher by two-fold in LAM nodule cells compared to control non-LAM lungs (p<0.05, Figure 1C). This evidence concerns the gene PLA2G4C and lymphangioleiomyomatosis.